The Multifunctional Contribution of FGF Signaling to Cardiac Development, Homeostasis, Disease and Repair

作者: Saverio Bellusci , Farhad Khosravi , Heinrich Sauer , Negah Ahmadvand

DOI: 10.3389/FCELL.2021.672935

关键词:

摘要: The current focus on cardiovascular research reflects society's concerns regarding the alarming incidence of cardiac-related diseases and mortality in industrialized world and, notably, an urgent need to combat them by more efficient therapies. To pursue these therapeutic approaches, a comprehensive understanding mechanism action for multifunctional fibroblast growth factor (FGF) signaling biology heart is matter high importance. roles FGFs development range from outflow tract formation proliferation cardiomyocytes chambers. In context cardiac regeneration, 1, 2, 9, 16, 19 21 mediate adaptive responses including restoration contracting rate after myocardial infarction reduction infarct size. However, complications human are correlated with pathogenic effects FGF ligands and/or impairment. 2 23 involved maladaptive such as hypertrophic, fibrotic failure. Among known causative (FGFs 23) or protective 15/19, 16 21) diseases, display diagnostic potential. effective role induction progenitor stem cells during has been employed boost limited capacity postnatal repair. renew replenish damaged cardiomyocytes, 10 were tested (induced-) pluripotent cell-based approaches stimulation cell cycle re-entry adult cardiomyocytes. This review will shed light wide beneficiary detrimental actions mediated their receptors heart, which may open new avenues ameliorating complications.

参考文章(210)
Chi Zhang, Zhifeng Huang, Junlian Gu, Xiaoqing Yan, Xuemian Lu, Shanshan Zhou, Shudong Wang, Minglong Shao, Fangfang Zhang, Peng Cheng, Wenke Feng, Yi Tan, Xiaokun Li, Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway Diabetologia. ,vol. 58, pp. 1937- 1948 ,(2015) , 10.1007/S00125-015-3630-8
Jitka A.I. Virag, Marsha L. Rolle, Julia Reece, Sandrine Hardouin, Eric O. Feigl, Charles E. Murry, Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair : Effects on Cell Proliferation, Scar Contraction, and Ventricular Function American Journal of Pathology. ,vol. 171, pp. 1431- 1440 ,(2007) , 10.2353/AJPATH.2007.070003
Yang Xiao, Lingjiao Liu, Aimin Xu, Pengcheng Zhou, Zhaofeng Long, Yiting Tu, Xiaoyan Chen, Weili Tang, Gan Huang, Zhiguang Zhou, Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes Cardiovascular Diabetology. ,vol. 14, pp. 72- 72 ,(2015) , 10.1186/S12933-015-0229-9
Daniyil A Svystonyuk, Janet MC Ngu, Holly EM Mewhort, Brodie D Lipon, Guoqi Teng, David G Guzzardi, Getanshu Malik, Darrell D Belke, Paul WM Fedak, Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling. Journal of Translational Medicine. ,vol. 13, pp. 147- 147 ,(2015) , 10.1186/S12967-015-0510-4
Eyad Nusayr, Thomas Doetschman, Betty Glascock, Brian E. House, Stacey L. House, Jo El J. Schultz, Thomas Kimball, Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase Molecular and Cellular Pharmacology. ,vol. 2, pp. 143- 154 ,(2010) , 10.4255/MCPHARMACOL.10.20
Lena Mascheck, Fatemeh Sharifpanah, Suk Ying Tsang, Maria Wartenberg, Heinrich Sauer, Stimulation of cardiomyogenesis from mouse embryonic stem cells by nuclear translocation of cardiotrophin-1 International Journal of Cardiology. ,vol. 193, pp. 23- 33 ,(2015) , 10.1016/J.IJCARD.2015.05.019
Olaf Bergmann, Sofia Zdunek, Anastasia Felker, Mehran Salehpour, Kanar Alkass, Samuel Bernard, Staffan L. Sjostrom, Mirosława Szewczykowska, Teresa Jackowska, Cris dos Remedios, Torsten Malm, Michaela Andrä, Ramadan Jashari, Jens R. Nyengaard, Göran Possnert, Stefan Jovinge, Henrik Druid, Jonas Frisén, Dynamics of Cell Generation and Turnover in the Human Heart Cell. ,vol. 161, pp. 1566- 1575 ,(2015) , 10.1016/J.CELL.2015.05.026
Nobuyuki Itoh, Hiroya Ohta, Morichika Konishi, Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy. Frontiers in Endocrinology. ,vol. 6, pp. 154- 154 ,(2015) , 10.3389/FENDO.2015.00154
Anna Planavila, Ibon Redondo-Angulo, Francesc Villarroya, FGF21 and Cardiac Physiopathology. Frontiers in Endocrinology. ,vol. 6, pp. 133- 133 ,(2015) , 10.3389/FENDO.2015.00133
Thomas Walther, Thomas Braun, Sawa Kostin, Thomas Kubin, Manfred Richter, Hans-Jürgen Lautze, The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation Journal of Heart and Lung Transplantation. ,vol. 34, pp. 1211- 1214 ,(2015) , 10.1016/J.HEALUN.2015.06.007